Midstream urine from 237 patients with significant bacteriuria were tested for antibody coated bacteria strattera 25mg (ACB): 113 urine gave a positive result. When more than 25,000 organisms ACB-positive urine were scanned or less than 100 to more than 250 luminescent bacteria (eg 1%) was found: thus, the distribution of fluorescent bacteria were bimodal. To compare the effectiveness of therapy in patients with ACB-positive and negative ACB-bacteriuria, 120 randomly selected patients received a 7-day course of appropriate therapy. Results were evaluated after 6 weeks. In 66 ACB-negative patients treatment was 84g8%, which is not significantly different than found in 26 patients (80g7%), whose urine contained ACB in a small amount (1%). In contrast, in 28 patients in which urine contains 1% ACB treatment only 36%. There was no correlation between surface immunoglobulin and bacterial response to therapy. The presence of 1% of ASV in midstream urine thus identifying patients at high risk of clinical failure. .
No comments:
Post a Comment